Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz Formulations in HIV-infected Children
NCT00364793Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2007
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Feb 2007; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00364793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364793.